Catalyst Capital Advisors LLC Amgen Inc Transaction History

Catalyst Capital Advisors LLC

$4.41 Billion
Q3 2024

A detailed history of Catalyst Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 414 shares of AMGN stock, worth $108,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares

414

Previous 514 19.46%

Holding current value

$108,563

Previous $160,000 16.88%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $30,938 - $33,738	-100 Reduced 19.46%	414 $133,000
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $2,890 - $3,512	11 Added 2.19%	514 $160,000
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $135,241 - $163,253	503 New	503 $143,000
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $22,083 - $27,417	101 Added 34.35%	395 $106,000
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $2,999 - $3,547	-14 Reduced 4.55%	294 $65,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $24,611 - $29,996	-109 Reduced 26.14%	308 $74,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $2,290 - $2,910	-10 Reduced 2.34%	417 $110,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $4,040 - $4,556	-18 Reduced 4.04%	427 $96,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $12,919 - $14,377	56 Added 14.4%	445 $108,000
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $16,445 - $18,192	75 Added 23.89%	389 $94,000
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $5,369 - $6,145	-27 Reduced 7.92%	314 $71,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $2,759 - $3,233	-13 Reduced 3.67%	341 $73,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $2,802 - $3,109	12 Added 3.51%	354 $86,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $15,089 - $17,584	-68 Reduced 16.59%	342 $85,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $88,715 - $105,644	410 New	410 $94,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $20.6 Million - $23.2 Million	-113,685 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $16.9 Million - $19.7 Million	94,693 Added 498.59%	113,685 $22.1 Million
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $276,452 - $311,663	1,492 Added 8.53%	18,992 $3.94 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $645,270 - $724,777	-3,886 Reduced 18.17%	17,500 $3.23 Million
Q1 2018 May 18, 2018	BUY	$169.43 - $198.0 $3.43 Million - $4.01 Million	20,236 Added 1759.65%	21,386 $3.65 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $192,383 - $219,650	1,150	1,150 $214,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Account

Catalyst Capital Advisors LLC Amgen Inc Transaction History